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Abstract
Background: This paper describes the study protocol, the recruitment, and base-line data for evaluating the success of
randomisation of the PRO-AGE (PRevention in Older people – Assessment in GEneralists' practices) project.
Methods/Design: A group of general practitioners (GPs) in London (U.K.), Hamburg (Germany) and Solothurn (Switzerland)
were trained in risk identification, health promotion, and prevention in older people. Their non-disabled older patients were
invited to participate in a randomised controlled study. Participants allocated to the intervention group were offered the Health
Risk Appraisal for Older Persons (HRA-O) instrument with a site-specific method for reinforcement (London: physician
reminders in electronic medical record; Hamburg: one group session or two preventive home visits; Solothurn: six-monthly
preventive home visits over a two-year period). Participants allocated to the control group received usual care. At each site, an
additional group of GPs did not receive the training, and their eligible patients were invited to participate in a concurrent
comparison group. Primary outcomes are self-reported health behaviour and preventative care use at one-year follow-up. In
Solothurn, an additional follow-up was conducted at two years. The number of older persons agreeing to participate (% of
eligible persons) in the randomised controlled study was 2503 (66.0%) in London, 2580 (53.6%) in Hamburg, and 2284 (67.5%)
in Solothurn. Base-line findings confirm that randomisation of participants was successful, with comparable characteristics
between intervention and control groups. The number of persons (% of eligible) enrolled in the concurrent comparison group
was 636 (48.8%) in London, 746 (35.7%) in Hamburg, and 1171 (63.0%) in Solothurn.
Discussion: PRO-AGE is the first large-scale randomised controlled trial of health risk appraisal for older people in Europe. Its
results will inform about the effects of implementing HRA-O with different methods of reinforcement.
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Background
The development and implementation of effective inter-
ventions to prevent or delay disability in older people is
an important public health priority. One promising
approach is based on Health Risk Appraisal (HRA). HRA
interventions were originally developed in the U.S. and
tested in working age adults with the aim of identifying
risks and decreasing the rate of premature illness and mor-
tality [1]. Subsequently, HRA was adapted for use in older
persons, emphasising health behaviour and preventative
care in this age group [2-5]. Multiple controlled trials con-
ducted in the United States addressed short or medium
term effects of HRA and showed positive effects on health
behaviour and uptake of preventative care in older per-
sons, provided HRA was combined with a system of per-
sonal reinforcement (supplemental counselling by a
physician, health educator, or other health professional)
[3].
Until now, the effects of HRA in older persons have not
been evaluated in European settings. The effects of the
intervention might be influenced by the characteristics of
health care systems or cultural factors that differ between
North America and Europe. The PRO-AGE (PRevention in
Older people – Assessment in GEneralists' practices)
project was carried out in London (U.K.), Hamburg (Ger-
many) and Solothurn (Switzerland) to examine the effects
of a HRA for Older Persons (HRA-O) [5-8]. Here we
describe the study protocol of the PRO-AGE project, and
report findings related to the recruitment process and the
randomisation of study participants.
Methods/Design
The PRO-AGE project took place in three locations: the
cities of London (U.K.) and Hamburg (Germany) and
selected rural areas of the canton of Solothurn (Switzer-
land). The overall study protocol is summarised in Figure
1, and the recruitment process is given for each site sepa-
rately (Figures 2, 3, 4). The study was approved by the
regional ethical committees (see Acknowledgment section
for details).
Recruitment of general practitioners (GPs)
In London, the criteria for inclusion of general practition-
ers (GPs) were a known interest in primary care for older
people, routine use of computerised practice information
systems, and practice location in suburban London. Over-
all, 4 group practices with a total of 26 GPs were recruited
(Figure 2). The independent study centre randomly allo-
cated three group practices (18 GPs) to training in risk
identification and preventative geriatrics, and one group
practice (8 GPs) to the concurrent comparison group.
In Hamburg, GPs registered in the entire metropolitan
area were invited to participate via the newsletter of their
regional GP association (BDA-Landesverband Hamburg).
Overall, 21 GPs (organised in solo practices) agreed to
participate (Figure 3) and the Hamburg study centre
formed seven groups of three GPs matched for physician
age, gender, and qualification (family practice versus
internal medicine). In each group of three practitioners,
the Hamburg study centre allocated two GPs to training
and one GP to the concurrent comparison cohort.
In Solothurn, the cantonal authority selected three mainly
rural primary care service areas. The Solothurn study cen-
tre obtained agreement to participate from all 33 GPs
practising in these pre-selected areas (Figure 4). In each
project area, these GPs (mostly organised in single-
handed or small group practices) collaborated in practice
circles consisting of 8 to 14 GPs each. Each practice circle
had monthly meetings to organise emergency care in the
region, to exchange practice policy information, and for
continuing education. The independent study centre ran-
domly allocated two practice circles to training and those
from the remaining circle to the concurrent comparison
group.
Recruitment of older persons
Participating GPs recruited older persons to the project in
four steps (Figure 1). Firstly, all practices generated lists of
their older patients. The age cut-off for listing patients was
based on the country-specific age used for planning and
delivery of services to the elderly. In London and Solo-
thurn, an age cut-off of 65 years was selected, in Hamburg
a cut-off of 60 years. In a second step, practices were asked
to exclude patients meeting the following exclusion crite-
ria: needing human assistance for performing basic activ-
ities of daily living or living in a nursing/residential home
(in Germany, nursing care according to the German long-
term care insurance system); cognitive impairment (i.e.
possible dementia, equivalent to a Mini Mental Status
score of 24 or less [9]; terminal disease; and/or inability to
speak the regional language. In a third step, GPs sent an
invitation letter to all individuals remaining on the list.
The invitation included an information sheet describing
the planned project, the Pra (Probability of repeated
admissions) questionnaire [10,11], and a self-adminis-
tered question on self-perceived need for human help in
basic activities of daily living [12]. Patients were asked to
return the completed questionnaire if they were interested
in participating in the study, and to give informed consent
according to the policies of the responsible institution. In
London and Solothurn patients were asked to complete
and return a written consent form. In Hamburg patients
were informed that by returning the questionnaire they
agreed to participate in the study. All patients were
informed that they could withdraw from the project with-
out negative impact on their care. In a fourth step, persons
reporting a need for human assistance in performing basicBMC Medical Research Methodology 2007, 7:2 http://www.biomedcentral.com/1471-2288/7/2
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Overall design of PRO-AGE study at the three participating sites (BADL denotes basic activities of daily living; HRA-O denotes  Health Risk Appraisal for Older Persons; Pra denotes Probability of repeated admissions) Figure 1
Overall design of PRO-AGE study at the three participating sites (BADL denotes basic activities of daily living; HRA-O denotes 
Health Risk Appraisal for Older Persons; Pra denotes Probability of repeated admissions)
General practitioners willing to participate in study
Site-specific allocation of general practitioners
General practitioners received training General practitioners did not receive training
List of all subjects aged 65 years
and older (London, Solothurn)/
60 years and older (Hamburg)
 Excluded
 - Dependent in BADL or living in
   nursing home
 - Cognitive impairment
 - Terminal disease
 - Did not speak regional language
Sent Pra questionnaire (plus BADL question)
 Excluded
 - Dependent in BADL
 - Returned incomplete
   Pra questionnaire
 Non-response
Randomisation of included older persons
Allocated to intervention (including
HRA-O questionnaire, feedback, and
site-specific intervention)
Allocated to control
(did not receive intervention)
 Excluded
 - Died
 - Living in nursing
   home
 - Moved away
Sent 1-year follow-up
questionnaire (HRA-O, health care
use and self-efficacy questions)
Solothurn only:
2-year follow-up questionnaire
(Healthtrac) and chart abstraction
 Excluded
 - Died
 - Living in nursing
   home
 - Moved away
 Excluded
 - Died
 - Living in nursing home
 - Moved away
 Excluded
 - Died
 - Living in nursing home
 - Moved away
Concurrent comparison group
(did not receive intervention)
 Excluded
 - Died
 - Living in nursing
   home
 - Moved away
 Excluded
 - Dependent in BADL
 - Returned incomplete
   Pra questionnaire
 Non-response
 Excluded
 - Dependent in BADL or living in
   nursing home
 - Cognitive impairment
 - Terminal disease
 - Did not speak regional language
Sent 1-year follow-up
questionnaire (HRA-O,
health care use and self-
efficacy questions)
Sent Pra questionnaire (plus BADL question)
List of all subjects aged 65 years
and older (London, Solothurn)/
60 years and older (Hamburg)
Sent 1-year follow-up
questionnaire (HRA-O, health care
use and self-efficacy questions)
Solothurn only:
2-year follow-up questionnaire
(Healthtrac) and chart abstractionBMC Medical Research Methodology 2007, 7:2 http://www.biomedcentral.com/1471-2288/7/2
Page 4 of 15
(page number not for citation purposes)
Recruitment and allocation of older persons in London (U.K.) (BADL denotes basic activities of daily living; HRA-O denotes  Health Risk Appraisal for Older Persons; Pra denotes Probability of repeated admissions) Figure 2
Recruitment and allocation of older persons in London (U.K.) (BADL denotes basic activities of daily living; HRA-O denotes 
Health Risk Appraisal for Older Persons; Pra denotes Probability of repeated admissions)
26 general practitioners (4 practice groups)
Random allocation of practice groups
3 practice groups (18 general practitioners)
allocated to training
1 practice group (8 general practitioners)
allocated to comparison (no training)
List of subjects aged 65 years and older
assessed for eligibility (n = 4466)
Total excluded (n = 391)
 - Dependent in BADL or living in
   nursing home (n = 284)
 - Cognitive impairment (n = 65)
 - Terminal disease (n = 27)
 - Language (n = 15)
Sent Pra questionnaire (n = 4075)
Total excluded (n = 280)
 - Dependent in BADL (n = 117)
 - Returned incomplete brief
   questionnaire (n = 163)
Total non-response (n = 1292)
Randomised (n = 2503)
Ratio 1 : 1
 Allocated to intervention
 - Sent HRA-O questionnaire and
   offered site-specific intervention
   (n = 1240)
 Participation in the intervention
 - Completed HRA-O questionnaire
   (n = 1090)
 - Did not complete HRA-O
   questionnaire (n = 150)
Allocated to control
Usual care (n = 1263)
Concurrent comparison group
Usual care (n = 636)
Sent Pra questionnaire (n = 1392)
List of subjects aged 65 years and older
assessed for eligibility (n = 1516)
Total excluded (n = 124)
 - Dependent in BADL or living in
   nursing home (n = 40)
 - Cognitive impairment (n = 23)
 - Terminal disease (n = 56)
 - Language (n = 5)
Total excluded (n = 89)
 - Dependent in BADL
   (n = 43)
 - Returned incomplete brief
   questionnaire (n = 46)
Total non-response
(n = 667)BMC Medical Research Methodology 2007, 7:2 http://www.biomedcentral.com/1471-2288/7/2
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Recruitment and allocation of older persons in Hamburg (Germany) (BADL denotes basic activities of daily living; HRA-O  denotes Health Risk Appraisal for Older Persons; Pra denotes Probability of repeated admissions) Figure 3
Recruitment and allocation of older persons in Hamburg (Germany) (BADL denotes basic activities of daily living; HRA-O 
denotes Health Risk Appraisal for Older Persons; Pra denotes Probability of repeated admissions)
21 general practitioners
Allocation of individual practitioners
14 general practitioners
allocated to training
7 general practitioners allocated to comparison
(no training)
List of subjects aged 60 years and older
assessed for eligibility (n = 6195)
Total excluded (n = 1324)
 - Dependent in BADL or living in
   nursing home (n = 558)
 - Cognitive impairment (n = 592)
 - Terminal disease (n = 87)
 - Language (n = 87)
Sent Pra questionnaire (n = 4871)
Total excluded (n = 62)
 - Dependent in BADL (n = 58)
 - Returned incomplete brief
   questionnaire (n = 4)
Total non-response (n = 2229)
Randomised (n = 2580)
Ratio 1 : 2
Allocated to intervention
 - Sent HRA-O questionnaire and
   offered site-specific intervention
   (n = 878)
 Participation in the intervention
 - Completed HRA-O and participated
      in group sessions (n = 503)
 - Completed HRA-O and accepted
      home visits (n = 77)
 - Completed HRA-O questionnaire
      only (n = 224)
 - Did not complete HRA-O
      questionnaire (n = 74)
Allocated to control
Usual care (n = 1702)
Concurrent comparison group
Usual care (n = 746)
Sent Pra questionnaire (n = 2115)
List of subjects aged 60 years and older
assessed for eligibility (n = 2885)
Total excluded (n = 770)
 - Dependent in BADL or living in
   nursing home (n = 229)
 - Cognitive impairment (n = 298)
 - Terminal disease (n = 179)
 - Language (n = 64)
Total excluded (n = 26)
 - Dependent in BADL
(n = 26)
 - Returned incomplete brief
questionnaire (n = 0)
Total non-response
(n = 1343)BMC Medical Research Methodology 2007, 7:2 http://www.biomedcentral.com/1471-2288/7/2
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Recruitment and allocation of older persons in Solothurn (Switzerland) (BADL denotes basic activities of daily living; HRA-O  denotes Health Risk Appraisal for Older Persons; Pra denotes Probability of repeated admissions) Figure 4
Recruitment and allocation of older persons in Solothurn (Switzerland) (BADL denotes basic activities of daily living; HRA-O 
denotes Health Risk Appraisal for Older Persons; Pra denotes Probability of repeated admissions)
33 general practitioners (3 practice circles)
Random allocation of practice circles
2 practice circles (19 general practitioners)
allocated to training
1 practice circle (14 general practitioners)
allocated to comparison (no training)
List of subjects aged 65 years and older
assessed for eligibility (n = 4115)
Total excluded (n = 505)
 - Dependent in BADL or living in
   nursing home (n = 266)
 - Cognitive impairment (n = 108)
 - Terminal disease (n = 109)
 - Language (n = 22)
Sent Pra questionnaire (n = 3610)
Total excluded (n = 228)
 - Dependent in BADL (n = 117)
 - Returned incomplete brief
   questionnaire (n = 111)
Total non-response (n = 1098)
Randomised (n = 2284)
Ratio 1 : 1.6
 Allocated to intervention
 - Sent HRA-O questionnaire and
   offered site-specific intervention
   (n = 874)
 Participation in the intervention
 - Completed HRA-O questionnaire
   plus home visits over two years
   (n = 514)
 - Completed HRA-O questionnaire
   and did not have home visits over
   two years (n = 234)
 - Did not complete HRA-O
   questionnaire (n = 126)
Allocated to control
Usual care (n = 1410)
Concurrent comparison group
Usual care (n = 1171)
Sent Pra questionnaire (n = 1987)
List of subjects aged 65 years and older
assessed for eligibility (n = 2214)
Total excluded (n = 227)
 - Dependent in BADL or living in
   nursing home (n = 125)
 - Cognitive impairment (n = 40)
 - Terminal disease (n = 46)
 - Language (n = 16)
Total excluded (n = 129)
 - Dependent in BADL
   (n = 75)
 - Returned incomplete brief
   questionnaire (n = 54)
Total non-response
(n = 687)BMC Medical Research Methodology 2007, 7:2 http://www.biomedcentral.com/1471-2288/7/2
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activities of daily living in the questionnaire, those return-
ing an incomplete Pra questionnaire, and those declining
participation (by not returning the brief questionnaire or
by returning the questionnaire with an explicit statement
of refusal) were excluded from the study. The remaining
persons were included in the final list of participants in
the study.
Randomisation of participants
Participating patients of GPs who had received the train-
ing were randomly allocated to intervention and control
groups by the independent study centre using a computer
generated allocation sequence. People living in the same
household were allocated to the same group. The ratio of
allocation of participants to intervention and control
groups was 1:1 in the London sample and 1:2 in the Ham-
burg sample. In the Solothurn sample, a 1:1 randomisa-
tion ratio was used in the initial study phase, and then
changed to 1:2, resulting in an average ratio of 1:1.6. Var-
iation in randomisation rates was related to budgetary
constraints (see sample size calculation), which became
apparent after the project was underway. Participants allo-
cated to the intervention group were offered HRA-O with
personal reinforcement. Those allocated to the control
group received usual care.
Participants of GPs who had not received additional train-
ing formed the concurrent comparison group. All patients
in this group continued to receive usual care during the
study period. GPs in this group received only general
project information during the study period, and were
offered the training after the end of the project follow-up.
Final inclusion of study participants started in November
2000 and was completed in London in October 2001, in
Hamburg in September 2001, and in Solothurn in Febru-
ary 2002.
The intervention
General goals of the interventions
The intervention evaluated in this trial consists of several
components as summarised in Table 1. All components
are based on the principles of risk and problem identifica-
tion, achievement of favourable behaviour changes in
older persons, and facilitation of preventative care use.
The intervention consists of a written component (HRA-O
questionnaire and feedback reports to older persons and
providers) and personal patient education using multiple
modalities with involvement of GPs and other health care
professionals.
Training of health professionals
GPs (and practice nurses in London) allocated to training
were trained in risk identification, health promotion and
prevention in older persons. This included initial (dura-
tion about 2 hours) and follow-up (every two to three
months) interactive training group sessions in risk and
problem identification, and in prevention and health pro-
motion for older persons. Training sessions were led by
one of the project physicians with expertise in preventa-
tive geriatric medicine. GPs were updated on emerging
evidence, health promotion and preventative messages
were reinforced, difficulties encountered as part of the
study raised, and problem solving strategies discussed. As
a reference guide, an evidence-based training manual was
developed. This manual explained the HRA-O approach,
and contained current preventative care recommenda-
tions for each of the domains included in the HRA-O with
relevant literature related to the management of each of
the domains and references supporting the recommenda-
tions made to both participants and their physicians [see
Additional file 1]. This manual was also used as a basis for
training of the other health professionals involved in the
intervention.
Use of HRA-O instrument
The intervention is based on the HRA-O instrument con-
sisting of a self-administered HRA-O questionnaire, a per-
sonalised feed-back report to the older person and a
summary feed-back report for the GP or the health educa-
tor. The development, practicability and performance of
the HRA-O questionnaire are described in a separate pub-
lication [7]. Briefly, the HRA-O questionnaire contains the
following sections: Administrative information (name,
address, date of birth, date of completion, completion
time); self-reported chronic conditions, preventative care
use, medication use, signs and symptoms, self-perceived
health, physical activity, nutrition, injury prevention,
tobacco use, alcohol use, eyesight, hearing, depressive
symptoms, self-reported memory, social network, social
support, basic and instrumental activities of daily living,
socio-economic information (education, occupation, liv-
ing arrangement, and selected additional items at each
site, such as information on state pension in London),
and health measurements (weight, height, blood pres-
sure, cholesterol). In addition, it contains additional
items based on the transtheoretical model of behaviour
change, as a basis for addressing the participants' readi-
ness to change and self-perceived barriers to changing
health behaviour in the feed-back statements [13]. Com-
pleted questionnaires are entered into the computer, and
an algorithm-based method automatically generates sum-
mary reports for the involved health professionals, as well
as personalised feed-back reports for the participants. This
includes individually tailored information and recom-
mendations based on the older persons' responses to the
questionnaire, general health information on each
domain addressed in the HRA-O questionnaire, and
sources of further information in the community.BMC Medical Research Methodology 2007, 7:2 http://www.biomedcentral.com/1471-2288/7/2
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In the PRO-AGE study, GPs or the study centre posted the
approximately 34-page HRA-O questionnaire to all indi-
viduals allocated to the intervention arm and asked them
to complete the questionnaire on their own or with the
support of a proxy [7]. Participants who completed the
HRA-O questionnaire and their health care providers
received the computer-generated personalised feed-back
reports generated by the study centre at each project site.
Reinforcement of HRA-O
GPs (and practice nurses in London) were encouraged to
reinforce the HRA-O during usual encounters with their
patients. GPs were encouraged to verify problems and
risks identified with the HRA-O questionnaire, and to
reinforce HRA-O based recommendations by motivating
patients to change their behaviour, or by facilitating pre-
ventative care uptake. In addition, participant reports
encouraged patients to discuss identified risks and written
recommendations with their GP if necessary.
Additional reinforcement in London
London adopted a specific approach for using the pro-
vider summary report. From the physician summary
report, participating GPs chose to enter all or some of the
HRA-O feedback into the electronic patient record (EPR)
using the Read code system, (a coding system used for the
classification of medical problems in EPRs in the U.K.)
[14]. This choice was made by the patient's usual GP, who
marked the relevant sections of the provider feedback
report and passed it to a data entry clerk. The information
that the patient had completed the HRA-O questionnaire
and had therefore received written recommendations was
added as a reminder to the EPR, and in addition individ-
ual HRA-O identified risks were incorporated as remind-
ers to the problem list of the EPR to act as electronic
prompts when the record was accessed. Finally, the whole
provider summary report was scanned into the EPR as if it
were a hospital letter. It was left to the discretion of both
providers and patients how HRA-O identified issues were
addressed, be it directly, opportunistically during unre-
lated consultation, or not at all. Six months after receiving
the feedback report, patients in the intervention group
were sent a reminder card encouraging them to follow-up
the recommendations in their report and consult the prac-
tice team if necessary.
Additional reinforcement in Hamburg
In Hamburg, all patients allocated to the intervention
group were invited to participate in a 4-hour group ses-
sion at a geriatric centre or to receive two home visits by a
specially trained nurse [15-18]. Group sessions were given
jointly by an interdisciplinary team consisting of a geria-
trician, a physical therapist, a nutritionist, and a social
worker working with a structured programme focusing
first on successful aging, nutrition, preventative care, life-
style modification, physical activity, medication use,
social contacts, housing and living location and empha-
sising patient self-efficacy and empowerment. The second
part of the group session covered nutrition and physical
activity in more detail. The purpose was to encourage the
setting of individual goals. In the third part of the group
session participants received individual written recom-
Table 1: Description of the HRA-O intervention as implemented in the PRO-AGE study
Aspect of the intervention Description
General goals of the To identify risks for functional decline and problems
intervention To achieve favourable change in health-related behaviour
To facilitate preventative care use
Training of health professionals Use of a specially prepared manual as a basis for training of GPs and additional health professionals involved in the 
intervention (copy available, see additional available material)
Initial and follow-up training of GPs and additional health professionals involved in the intervention in groups, led 
by one of the project physicians trained in preventative geriatric medicine
Use of HRA-O instrument Mailing of HRA-O questionnaire to participants (copy available, see reference No. 7)
Written individualised participant feed-back report
Written provider HRA-O summary feed-back report
Personal reinforcement of  GP verifies presence of identified risks and problems (as described in HRA-O summary report)
HRA-O by GP Patient discusses recommendations of participant feed-back report with their GP (opportunistically at GP-patient 
encounter)
GP motivates the patient to favourably change health behaviour and use recommended preventative care 
(opportunistically at GP-patient encounter)
Additional site-specific  London: GP gets reminders of identified risks and problems in EMR
reinforcement Hamburg: Participants are offered one group session by interdisciplinary team or two home visits by nurse
Solothurn: Participants are offered six-monthly home visits by health nurses over a two-year period
HRA-O: Health Risk Appraisal for Older Persons
PRO-AGE: PRevention in Older people – Assessment in GEneralists' practices
GP: General practitioner
EMR: Electronic medical recordBMC Medical Research Methodology 2007, 7:2 http://www.biomedcentral.com/1471-2288/7/2
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mendations from members of the interdisciplinary team
[15,16]. Older persons who preferred home visits were
offered two home visits (after base-line and at six months)
by a specially trained nurse who conducted an additional
multidimensional assessment of nutrition, medication
use, pain, mobility, cognition, vision, and hearing, prior-
itised recommendations and follow-up for adherence
with the recommendations [17,18].
Additional reinforcement in Solothurn
In Solothurn, all participants who returned the HRA-O
questionnaire were offered home visits by specially
trained health nurses. The nurses discussed the participant
feed-back on the completed HRA-O questionnaire with
the older persons, answered questions from patients, and
conducted a detailed interview on physical activity and
medication use in all patients. If needed, they conducted
additional assessments in the areas of nutrition, medica-
tion use, pain, mobility, cognition, vision, and hearing.
Nurses discussed each case with a project geriatrician, and
subsequently with the GP. Recommendations were prior-
itised, reinforced or formulated in more detail (e.g., defi-
nition of specific recommendations related to physical
activity), and if new risks were identified, new recommen-
dations were formulated. Based on the transtheoretical
model of behaviour change nurses attempted to achieve
behaviour change by taking into account individual read-
iness to change and negotiating realistic goals with the
older persons. Subsequently, nurses conducted follow-up
visits at 6-monthly intervals, with interim phone calls to
patients as needed over a two-year period. At one year, the
nurses conducted a yearly assessment home visit based on
the follow-up HRA-O and on additional assessments as
needed. Further funding, secured once the project was
underway, enabled the duration of the intervention to be
extended to two years in Solothurn. This allowed longer-
term follow-up of the effects of HRA-O combined with
preventive home visits.
Data collection
Prior to randomisation, participant age and gender were
recorded from practice registers. Information on base-line
self-perceived health status, prior health care use, and
instrumental support were derived from the Pra question-
naire [10]. In addition, for the participants in London, the
Townsend score [19], a measure of social deprivation
based on indicators of the older person's living location,
was derived from the participants' address information.
At the one-year follow-up, surviving participants of all
groups (intervention, control, and concurrent compari-
son group) were sent a HRA-O questionnaire with addi-
tional questions on health care use [10] and on patient
self-efficacy [20]. This follow-up questionnaire included
all items required for outcome analysis, as listed in Table
2. In addition, the one-year follow-up questionnaire was
used for obtaining information on socioeconomic infor-
mation and self-reported chronic conditions among par-
ticipants in the control and concurrent comparison
groups. No reminders were sent to persons not returning
this questionnaire. To reduce the amount of missing
information on preventative care in the London sample,
practices were asked to review patient medical records for
information on preventative care use (vaccination cover-
age, blood glucose and cholesterol measurement, colon
cancer screening) for patients who had returned the 1-year
follow-up questionnaire but had incomplete information
on some items of preventative care (n = 44 intervention
group, n = 33 control group, n = 20 concurrent compari-
son group).
In Solothurn, in addition to the one-year follow-up, a
two-year follow-up was conducted among persons in the
randomised study (not in the concurrent comparison
group). Health behaviour outcome data were collected
using a two-page questionnaire based on the Healthtrac
questionnaire [2]. In addition, older persons were asked
for their self-perceived health status, and for need for help
in basic activities of daily living. Non-responders or those
who returned incomplete questionnaires, were contacted
by telephone, or visited at home, and a trained research
assistant, blinded for group allocation, attempted to
obtain missing information. Selected preventative care
measures (those mainly offered by GPs, and not by spe-
cialists, in the Swiss health care system) and selected
health measurements (most recent values of blood based
measurement, serum cholesterol, and serum glucose)
were obtained from a review of primary care medical
records. This abstraction of medical records was con-
ducted by practice assistants based on an alphabetised list
of participating patients blinded for group allocation.
At all sites, survival status and move into permanent long
term care among non-responders at follow-up was
obtained from GPs, and if available from registers in par-
ticipating regions. Move into permanent long-term care
was defined as living in a nursing home in London and
Solothurn, and in Hamburg as requiring nursing care
according to the German long-term care insurance system.
At the end of the follow-up period (London and Ham-
burg, at one-year follow-up, Solothurn at two-year-fol-
low-up), participating GPs and other health personnel
involved in the HRA-O intervention, received a structured,
uniform questionnaire for written feed-back on the
project.
Sample size/power calculation
We calculated the required sample size for detecting, at a
two-sided significance level of 0.05 and with a power ofBMC Medical Research Methodology 2007, 7:2 http://www.biomedcentral.com/1471-2288/7/2
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80%, a postulated 30% difference in positive health risk
behaviour or preventative care use in the intervention
group as compared to controls at the one-year follow-up.
For this calculation, a prevalence of positive behaviour or
preventative care use among controls of 20% was
assumed, based on pilot data in a comparable sample of
community-dwelling older persons [6]. Based on a 1:1
randomisation ratio and a predicted drop-out rate at one
year of 20%, the required sample size was 1000 persons
per group. In Hamburg and Solothurn, due to limitations
in resources available for offering the intervention (group
sessions, home visits), a randomisation rate of 1:2 was
preferable. Based on a 1:2 randomisation rate, and on the
same drop out rate, the required sample size was 763 per-
sons in the intervention group and 1525 persons in the
control group.
Statistical analyses
All analyses follow an a priori analytic plan. The primary
outcomes are health behaviour and preventative care use,
as listed in Table 2[2,5,21-25]. Secondary outcomes
include mortality, need for long-term care (living in nurs-
ing home, or designated as requiring long-term care
according to the German long-term care insurance sys-
tem), and self-reported information on health status
(vision, hearing, self-perceived health status, pain, depres-
sive symptoms, falls history, and functional status).
To conduct planned sensitivity and subgroup analyses of
primary outcomes, two composite scores will be created:
one for adherence to positive health behaviour, and one
for use of recommended preventative care. The percentage
of health behaviour domains (Table 2) for which the
patient showed a positive level of performance, and the
percentage of recommended preventative care measures
(Table 2) the patient had used will be determined. We will
impute composite scores for individuals in whom ≤ 20%
of the required outcome data were missing. Imputation
will be conducted as follows: based on available baseline
variables multiple linear regression models (using the
complete base-line information and household status)
will be derived in the subset of persons with complete
data on outcomes, and subsequently, these models will be
used to impute composite score estimates in persons with
missing information.
Outcome analyses of the randomised controlled study
will be conducted for each site separately in keeping with
the inter-site variations of reinforcement methods. The
main analyses will compare primary and secondary out-
comes between intervention and control groups at follow-
up. In these analyses, the fact that participants living in the
same household were allocated to the same group will be
taken into account by adding the information on house-
hold membership to generalised estimating equations
Table 2: List of primary outcomes used in the PRO-AGE study at the follow-up: health behaviour and preventative care use
Domain One-year outcome analysis (all sites) Two-year outcome analysis (Solothurn only)
Health behaviour
-Accident prevention Driving without using seat belt [22] Driving without using seat belt [2]
-Alcohol use Possible hazardous or harmful alcohol use: based on 
age-and gender-specific limits of quantity and frequency 
of use [23]
Possible hazardous alcohol use: ≥ 2 drinks/day [2]
-Nutrition intake Consumption of >2 high-fat food items per day [24] Daily consumption of high-fat food items [2]
Consumption of <5 fruit/fibre items per day [24] Less than daily consumption of fruit and fibre items [2]
-Physical activity Moderate or strenuous activity < 5 times/week [25] Physical activity < 5 times/week [2]
-Tobacco use Current tobacco use [5] Current tobacco use [2]
Preventative care use [21]
-Blood pressure Self-report: blood pressure control in previous year Medical record: blood pressure control in previous year
-Breast cancer screening Self-report: mammography in previous 2 years n.a.
-Cholesterol Self-report: cholesterol measurement in previous 5 
years
Medical record: cholesterol measurement in previous 5 
years
-Colon cancer screening Self-report: faecal occult blood test in previous year Medical record: faecal occult blood test in previous year
-Dental care Self-report: dental check in previous year n.a.
-Diabetes screening Self-report: blood glucose measurement in previous 3 
years
Medical record: blood glucose measurement in previous 
3 years
-Hearing examination Self-report: hearing check-up in previous year n.a.
-Influenza immunisation Self-report: influenza vaccination in previous year Medical record: influenza vaccination in previous year
-Pneumococcal immunisation Self-report: pneumococcal vaccination (ever) Medical record: pneumococcal vaccination (ever)
-Vision examination Self-report: vision check-up in previous year n.a.
PRO-AGE: PRevention in Older people – Assessment in GEneralists' practices
n.a. denotes not availableBMC Medical Research Methodology 2007, 7:2 http://www.biomedcentral.com/1471-2288/7/2
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(GEE) models [26,27]. Subgroup analyses will be used to
evaluate whether the intervention effects differ between
predefined subgroups of the population. Firstly, out-
comes will be compared between older persons at high
risk (Pra > 0.28) and those at low risk (Pra ≤ 0.28) for hos-
pital use [10,11], based on the hypothesis that this type of
intervention might have greater positive effects in persons
at low risk [28]. Second, for the randomised study in
Hamburg and Solothurn, an additional analysis will be
carried out to evaluate the independent effects of the site-
specific reinforcement on primary outcomes: multivariate
regression analyses will be conducted using the composite
scores as outcome variables, and participation status in
the reinforcement as an independent variable, controlling
for intervention allocation status and available participant
base-line characteristics. Finally, sensitivity analyses will
be conducted to evaluate for potential bias resulting from
missing outcome data. First, all analyses will be repeated
by adjusting GEE models for base-line age, gender, self-
perceived health and number of physician visits reported.
Second, primary outcome analyses will be repeated by
using with composite scores of health behaviour and use
of preventative care which will be derived from imputed
outcome estimates in persons with partially missing infor-
mation.
We will also evaluate changes in preventative care use,
health behaviour, and health status between baseline and
the one-year follow-up among persons in the intervention
group. This analysis will be possible because persons in
the intervention group received the HRA-O questionnaire
both at base-line and at one-year follow-up. This analysis
will adjust for household membership and base-line vari-
ables (age, gender, self-perceived health status, health care
use prior to base-line). These pre-post analyses will be
restricted to the intervention group since primary out-
comes were not measured in the control group at baseline.
Outcome analysis of data from the concurrent compari-
son group will include a comparison of primary and sec-
ondary outcomes between the intervention group and the
concurrent comparison group. The primary analysis will
be a comparison of primary outcomes adjusted for base-
line factors.
Categorical and binary outcome data will be analysed
using chi-square tests; continuous outcome data will be
compared using t-tests if normally distributed, Mann-
Whitney U test if skewed. Number of physician visits will
be analysed with ordered logistic regression models. To
allow for within-household clustering, Generalised Esti-
mating Equations (GEE), assuming an exchangeable cor-
relation structure, will be used to analyse all outcomes
[27]. Data will be analysed using the SAS programme
[29].
Recruitment and inclusion of study participants
Figures 2 to 4 depict the flow of study participants in Lon-
don, Hamburg, and Solothurn. As shown, the percentage
of participating older persons varied according to study
site. Among patients of trained physicians, the numbers of
older persons (% of eligible) agreeing to participate were
2503 (66.0%) in London, 2580 (53.6%) in Hamburg,
and 2284 (67.5%) in Solothurn. In the concurrent com-
parison group, the number of persons (% of eligible)
agreeing to participate was 636 (48.8%) in London, 746
(35.7%) in Hamburg, and 1171 (63.0%) in Solothurn.
Table 3 lists the results of the analyses comparing age and
gender of persons agreeing to participate with eligible
patients who declined. This analysis is based on multivar-
iate logistic regression analyses. In London those who
declined to participate were on average about one year
older than participants. A similar comparison of the
recruitment process of the Hamburg randomised study
did not reveal statistically significant differences. The
interpretability of the Hamburg data is limited because
demographic information was not available for a propor-
tion of non-participants due to state-mandated data pro-
tection issues. The comparison between participants and
non-participants of the Solothurn randomised study
revealed a gender difference, with men declining partici-
pation more often as compared to women. The compari-
son between participants and non-participants of the
Solothurn concurrent comparison group revealed the
same age difference as found in London, with non-
responders being approximately one year older as com-
pared to responders.
Comparison between groups of participants
Table 4 describes the available base-line characteristics of
the study participants according to study sites and group
allocation. This is to evaluate the success of randomisa-
tion. Within each site, prevalence rates were similar
between intervention and control groups. In contrast,
there were some relatively minor, but statistically signifi-
cant differences between persons of the concurrent com-
parison group and persons of the intervention group
(Table 4). Information on education, living alone status,
and chronic conditions was derived from baseline HRA-O
questionnaire (intervention groups: administered at the
start of the project after randomisation; control and con-
current comparison groups: administered at the one-year
follow-up). Missing values are due to non-response (all
groups) or attrition (death, move away, and move to nurs-
ing home) in the control and concurrent comparison
groups.
Discussion
To our knowledge this is the first randomised study of a
HRA-O intervention conducted in Europe. As shown inBMC Medical Research Methodology 2007, 7:2 http://www.biomedcentral.com/1471-2288/7/2
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this paper, the PRO-AGE project was successful in recruit-
ing the large number of older persons required to evaluate
– with adequate statistical power – the effects of a HRA-O
intervention on health behaviour and use of preventative
care. The PRO-AGE project has additional strengths. The
HRA-O intervention was implemented in three sites in
different countries, with different health care systems, dif-
ferent languages and different cultural backgrounds. Fur-
thermore, each site implemented an additional specific
reinforcement of the HRA-O. Thus, this study can evaluate
the effects of HRA-O with varying forms of reinforcement
in a broad range of older persons. Finally, based on the
planned risk-stratified analyses using the Pra question-
naire, it will be possible to evaluate whether effects are
Table 4: Self-reported baseline characteristics of the PRO-AGE study participants, according to site and group assignment
Baseline 
characteristics
London (U.K.) Hamburg (Germany) Solothurn (Switzerland)
Intervention 
group
Control group Concurrent 
comparison 
group
Intervention 
group
Control group Concurrent 
comparison 
group
Intervention 
group
Control group Concurrent 
comparison 
group
Age (years) 74.7 ± 6.4 
(1240)
74.4 ± 6.2 
(1263)
74.9 ± 6.5 
(636)
71.9 ± 7.7 
(878)
71.8 ± 7.6 
(1702)
72.0 ± 8.2 
(746)
74.5 ± 5.8 
(874)
74.5 ± 6.1 
(1410)
74.2 ± 6.0 
(1171)
Female gender 55.3% 
(686/1240)
54.6% 
(689/1263)
57.5% 
(366/636)
61.5% 
(540/878)
63.3% 
(1077/1702)
68.2%* 
(509/746)
56.9% 
(497/874)
56.5% 
(796/1410)
57.0% 
(667/1171)
Fair/poor self-
perceived health
24.5% 
(304/1240)
27.2% 
(343/1263)
27.4% 
(174/636)
38.6% 
(339/878)
38.5 
(656/1702)
39.5% 
(295/746)
19.9% 
(174/874)
24.8% 
(349/1410)
23.6% 
(276/1171)
≥1 hospital 
admission over 
past 12 months
14.0% 
(173/1240)
14.6%) 
(185/1263)
14.2% 
(90/636)
21.2% 
(186/878)
21.2% 
(360/1702)
22.5% 
(168/746)
19.9% 
(174/874)
18.5% 
(261/1410)
17.7% 
(207/1171)
> 6 doctor visits 
over past 12 
months
19.0% 
(236/1240)
24.3% 
(307/1263)
23.4% 
(149/636)
49.9% 
(438/878)
49.9% 
(849/1702)
44.0%* 
(328/746)
24.0% 
(210/874)
24.3% 
(343/1410)
28.7%* 
(336/1171)
No available 
caregiver if needed
17.6% 
(218/1240)
14.8% 
(187/1263)
19.2% 
(122/636)
17.8% 
(156/878)
18.9% 
(322/1702)
20.0% 
(149/746)
9.8% 
(86/874)
11.6% 
(163/1410)
8.8% 
(103/1171)
Pra score 0.27 ± 0.11 0.27 ± 0.11 0.27 ± 0.11 0.30 ± 0.11 0.30 ± 0.12 0.29 ± 0.11 0.29 ± 0.104 0.29 ± 0.11 0.30 ± 0.11
Low level of 
education
59.8% 
(666/1113)
62.5% 
(654/1046)
71.9%* 
(343/477)
18.8% 
(142/756)
23.5% 
(300/1277)
25.0%* 
(135/539)
47.7% 
(335/702)
43.2% 
(398/921)
41.9%* 
(337/804)
Living alone 33.6% 
(375/1116)
30.9% 
(324/1047))
36.4% 
(174/478)
35.0% 
(279/798)
37.4% 
(504/1349)
36.9% 
(206/559)
31.4% 
(234/745)
30.6% 
(299/976)
27.1% 
(229/845)
Three or more 
self-reported 
chronic conditions
33.3% 
(365/1095)
31.2% 
(324/1039)
39.0%* 
(183/469)
52.3% 
(399/763)
53.3% 
(691/1296)
52.3% 
(287/549)
39.5% 
(285/722)
39.6% 
(364/920)
42.6% 
(344/808)
Townsend score 1.1 ± 3.0 
(1197)
1.0 ± 3.0 
(1247)
4.4 ± 1.6 
(635)
n.a. n.a. n.a. n.a. n.a. n.a.
PRO-AGE: PRevention in Older people – Assessment in GEneralists' practices
n.a. denotes not available.
Values are percentages (nominator/denominator) or means ± standard deviations (denominator).
Statistically significant differences (bivariate analyses, P < 0.05) between intervention and concurrent comparison group are marked with an asterisk.
Pra score (Probability of repeated admissions): higher scores denote higher risk for hospital admission.
Townsend score: higher scores denote higher social deprivation.
Table 3: Comparison of participants and non-participants in the PRO-AGE study at the three study sites
London (U.K.) Hamburg (Germany) * Solothurn (Switzerland)
Participants Non-participants P-value Participants Non-participants P-value Participants Non-participants P-value
Randomised study
Age (years) 74.6 ± 6.3 (2503) 75.7 ± 7.3 (1292) <.0001 71.8 ± 7.6 (2580) 71.3 ± 8.1 (1234) 0.10 74.5 ± 6.0 (2284) 74.8 ± 6.8 (1098) 0.68
Female gender 54.9% (1375/2503) 58.3% (753/1292) 0.12 62.7% (1617/2580) 62.1% (821/1322) 0.70 56.6% (1293/2284) 52.7% (579/1098) 0.03
Concurrent comparison group
Age (years) 74.9 ± 6.5 (636) 75.9 ± 7.5 (667) 0.01 72.0 ± 8.2 (746) 71.3 ± 8.5 (631) 0.31 74.2 ± 6.0 (1171) 75.1 ± 6.8 (687) 0.01
Female gender 57.6% (366/636) 57.4% (383/667) 0.63 68.1% (508/746) 63.7% (690/1084) 0.001 57.0% (667/1171) 60.0% (412/687) 0.32
PRO-AGE: PRevention in Older people – Assessment in GEneralists' practices
Values are percentages (nominator/denominator) or means ± standard deviations (denominator).
P-values based on multivariable logistic regression models including age and gender.
* In Hamburg, information on age and gender was in part missing amongst non-participants due to state-mandated data protection regulations.BMC Medical Research Methodology 2007, 7:2 http://www.biomedcentral.com/1471-2288/7/2
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more positive in persons at low risk, as compared to per-
sons at high risk, as suggested by recent research evidence
[28].
The PRO-AGE project has several limitations. Firstly, one-
year outcome analysis is based on self-reported informa-
tion alone, and there is no systematic information from
direct patient observation, no cost data, and only limited
information from medical records available for this anal-
ysis. However, since we used validated instruments to
obtain information on a broad range of health-related
measures, the study will provide valid estimates on the
effects of HRA-O on health behaviour, preventative care
use, and health status in older persons.
Second, outcome data will not be available for a part of
the study participants due to missing data. Due to budget-
ary constraints it was not feasible to implement a
reminder system or use some other mechanism for
obtaining outcome data from persons who did not
respond or only partially responded to the one-year fol-
low-up questionnaire. The magnitude of this limitation
will depend on the percentage of missing information
among study participants at the three study sites. The
potential impact of missing data will be evaluated in sta-
tistical sensitivity analyses.
An additional limitation of the PRO-AGE study is the fact
that the study was not powered to measure the effects of
the intervention on the prevention of functional decline
and nursing home admissions. However, it is appropriate,
as a first step, to conduct a study for identifying effective
intervention methods in the short-term, and in a second
step, to plan new studies to evaluate the effects of an opti-
mised intervention strategy over longer time periods.
A further limitation of this study is the possibility of con-
tamination effects. Patients allocated to control groups
may have benefited from the intervention because they
received usual care from their GPs who had received spe-
cial training and were involved in the intervention (Table
1). In anticipation of this problem, the study design
includes outcome evaluations in a parallel concurrent
comparison group with patients receiving care from phy-
sicians who had not received training in preventative ger-
iatric medicine. A comparison between intervention and
concurrent comparison group is expected to give an esti-
mate of treatment effects without contamination bias, but
is limited due to potential selection bias. In fact, there
were some small but significant differences in base-line
characteristics between participants of the intervention
and concurrent comparison groups. Among other factors,
this might be related to the fact that the number of clusters
randomised was only 4 in London, and 3 in Solothurn. To
address this limitation, the analyses comparing outcomes
between intervention and concurrent comparison groups
will adjust for base-line characteristics.
In conclusion, recruitment of study participants to this
project was successful, and base-line findings confirm the
success of the randomisation and the comparability of
base-line characteristics between intervention and control
groups. The a priori analytic plan which examines inter-
vention effects takes into account the described limita-
tions, and includes sensitivity analyses evaluating
potential sources of bias. Furthermore, the database con-
taining cross-sectional and longitudinal information on
multiple health risks in older people will also be useful for
refining existing instruments or methods of risk predic-
tion in older people.
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